Armed with some Python and a white-hot sense of injustice, one medical student spent six months trying to figure out whether ...
FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results